CN117700363A - 吡唑衍生物 - Google Patents
吡唑衍生物 Download PDFInfo
- Publication number
- CN117700363A CN117700363A CN202311588227.8A CN202311588227A CN117700363A CN 117700363 A CN117700363 A CN 117700363A CN 202311588227 A CN202311588227 A CN 202311588227A CN 117700363 A CN117700363 A CN 117700363A
- Authority
- CN
- China
- Prior art keywords
- methyl
- formula
- pyrazol
- compounds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003217 pyrazoles Chemical class 0.000 title abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 80
- -1 tri-substituted pyrazole Chemical class 0.000 claims description 41
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 15
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 12
- 125000006677 (C1-C3) haloalkoxy group Chemical group 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical group 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000006001 difluoroethyl group Chemical group 0.000 claims description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 3
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 3
- WEFVKGVAZKQHBE-SNAWJCMRSA-N ethyl (E)-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]prop-2-enoate Chemical compound CN1N=C(C=C1C(F)(F)F)/C=C/C(=O)OCC WEFVKGVAZKQHBE-SNAWJCMRSA-N 0.000 claims description 2
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 2
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- OZOQNQXUSXKLFV-SNAWJCMRSA-N BrC1=C(N(N=C1Cl)C)/C=C/C(=O)OCC Chemical compound BrC1=C(N(N=C1Cl)C)/C=C/C(=O)OCC OZOQNQXUSXKLFV-SNAWJCMRSA-N 0.000 claims 1
- CTPOKMMWROIWGV-SNAWJCMRSA-N BrC1=NN(C(=C1/C=C/C(=O)OCC)Cl)C Chemical compound BrC1=NN(C(=C1/C=C/C(=O)OCC)Cl)C CTPOKMMWROIWGV-SNAWJCMRSA-N 0.000 claims 1
- GRFCUJCDYIYZLV-SNAWJCMRSA-N BrC=1C(=NN(C=1Cl)C)/C=C/C(=O)OCC Chemical compound BrC=1C(=NN(C=1Cl)C)/C=C/C(=O)OCC GRFCUJCDYIYZLV-SNAWJCMRSA-N 0.000 claims 1
- QVPYCSLBOOCBHD-SNAWJCMRSA-N CN1N=CC(=C1C(F)(F)F)/C=C/C(=O)OCC Chemical compound CN1N=CC(=C1C(F)(F)F)/C=C/C(=O)OCC QVPYCSLBOOCBHD-SNAWJCMRSA-N 0.000 claims 1
- CADRGOYEUZPQLD-SNAWJCMRSA-N ClC1=C(C=NN1C)/C=C/C(=O)OCC Chemical compound ClC1=C(C=NN1C)/C=C/C(=O)OCC CADRGOYEUZPQLD-SNAWJCMRSA-N 0.000 claims 1
- NSQDLMXYYMTNJX-SNAWJCMRSA-N ClC1=CC(=NN1C)/C=C/C(=O)OCC Chemical compound ClC1=CC(=NN1C)/C=C/C(=O)OCC NSQDLMXYYMTNJX-SNAWJCMRSA-N 0.000 claims 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 1
- 150000002829 nitrogen Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 7
- 239000003905 agrochemical Substances 0.000 abstract description 5
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 235000019439 ethyl acetate Nutrition 0.000 description 9
- 230000002363 herbicidal effect Effects 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 150000002431 hydrogen Chemical class 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 150000003571 thiolactams Chemical group 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 125000001188 haloalkyl group Chemical group 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- BJYIAUXMGMJTEY-UHFFFAOYSA-N N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxopyrrolidine-3-carboxamide Chemical compound FC1=C(C=CC=C1F)NC(=O)C1C(N(CC1C1=NN(C(=C1)C(F)(F)F)C)C)=O BJYIAUXMGMJTEY-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 125000004438 haloalkoxy group Chemical group 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 2
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- PAQZWJGSJMLPMG-UHFFFAOYSA-N 2,4,6-tripropyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 2
- YPIINMAYDTYYSQ-UHFFFAOYSA-N 5-ethenyl-1h-pyrazole Chemical class C=CC=1C=CNN=1 YPIINMAYDTYYSQ-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 2
- 101000603877 Homo sapiens Nuclear receptor subfamily 1 group I member 2 Proteins 0.000 description 2
- 101001098560 Homo sapiens Proteinase-activated receptor 2 Proteins 0.000 description 2
- 101000713170 Homo sapiens Solute carrier family 52, riboflavin transporter, member 1 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 102100036863 Solute carrier family 52, riboflavin transporter, member 1 Human genes 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000006352 cycloaddition reaction Methods 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- RGXWDWUGBIJHDO-UHFFFAOYSA-N ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCC RGXWDWUGBIJHDO-UHFFFAOYSA-N 0.000 description 2
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000006400 oxidative hydrolysis reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- BJYIAUXMGMJTEY-ISVAXAHUSA-N (3R,4S)-N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxopyrrolidine-3-carboxamide Chemical compound FC1=C(C=CC=C1F)NC(=O)[C@@H]1C(N(C[C@H]1C1=NN(C(=C1)C(F)(F)F)C)C)=O BJYIAUXMGMJTEY-ISVAXAHUSA-N 0.000 description 1
- BJYIAUXMGMJTEY-OQPBUACISA-N (3S,4R)-N-(2,3-difluorophenyl)-1-methyl-4-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-oxopyrrolidine-3-carboxamide Chemical compound FC1=C(C=CC=C1F)NC(=O)[C@H]1C(N(C[C@@H]1C1=NN(C(=C1)C(F)(F)F)C)C)=O BJYIAUXMGMJTEY-OQPBUACISA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 description 1
- MRGCXAIDVMLYSR-UHFFFAOYSA-N 1,3-dithiolan-2-ylidene-methyl-(trimethylsilylmethyl)azanium Chemical compound C[Si](C)(C)C[N+](C)=C1SCCS1 MRGCXAIDVMLYSR-UHFFFAOYSA-N 0.000 description 1
- YCCQGFYAVUTQFK-UHFFFAOYSA-N 2,3-difluoroaniline Chemical compound NC1=CC=CC(F)=C1F YCCQGFYAVUTQFK-UHFFFAOYSA-N 0.000 description 1
- NOIXNOMHHWGUTG-UHFFFAOYSA-N 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline Chemical compound C=1C=C(OCC=2N=C3C=CC=CC3=CC=2)C=CC=1C1=NN(CC(F)(F)F)C=C1C1=CC=NC=C1 NOIXNOMHHWGUTG-UHFFFAOYSA-N 0.000 description 1
- BFBKUYFMLNOLOQ-UHFFFAOYSA-N 2-butoxyethanamine Chemical compound CCCCOCCN BFBKUYFMLNOLOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- KUSYIGBGHPOWEL-UHFFFAOYSA-N 2-methyl nonaoic acid Chemical group CCCCCCCC(C)C(O)=O KUSYIGBGHPOWEL-UHFFFAOYSA-N 0.000 description 1
- PJHRMQPEENZCPK-UHFFFAOYSA-N 2-methylsulfanylpropan-1-amine Chemical compound CSC(C)CN PJHRMQPEENZCPK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PCHVEBIHYNZHNC-UHFFFAOYSA-N 4,6-dihydro-1h-pyrrolo[3,2-c]pyrazol-5-one Chemical group N1N=CC2=C1CC(=O)N2 PCHVEBIHYNZHNC-UHFFFAOYSA-N 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- OIFIKWIFICPTTR-UHFFFAOYSA-N Cn1nc(I)cc1C(F)(F)F Chemical compound Cn1nc(I)cc1C(F)(F)F OIFIKWIFICPTTR-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical group [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- QYLILOUBQHXUSZ-UHFFFAOYSA-N N=C=O.C1CSSC1 Chemical compound N=C=O.C1CSSC1 QYLILOUBQHXUSZ-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 150000003951 lactams Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006095 n-butyl sulfinyl group Chemical group 0.000 description 1
- 125000006126 n-butyl sulfonyl group Chemical group 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P13/00—Herbicides; Algicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
本发明涉及:具有式(X)的吡唑衍生物,其中环A是吡唑并且取代基RB1、RB2、n、RQ1、RQ2、RQ3和RQ4是如权利要求1中所定义的;所述吡唑衍生物的制造;以及所述吡唑衍生物在农用化学品和药物的制造中的用途。
Description
本申请是母案为中国发明专利申请202080012473.7的分案申请。
本发明涉及如本文中所述的具有式(X)的吡唑衍生物,其在农用化学品和药物的生产中是有价值的中间体。本发明延伸至此类吡唑衍生物的制造、及其随后在农用化学品和/或药物的制造中的用途。
在第一方面,本发明提供了一种具有式(X)的化合物
其中环A是二-或三-取代的吡唑,在一个环氮上被RB2取代并且在至少一个环碳上被RB3取代,其中RB2是C1-C3烷基或C1-C3氟烷基,n是1或2的整数并且每个RB3独立地是卤素、C1-C3氟烷基、C1-C3卤代烷氧基、C1-C3烷氧基、C1-C3卤代烷基、C1-C3氟烷基、C1-C3卤代烷氧基、C1-C3烷氧基、或C1-C3烷基;RQ1和RQ4各自是氢,并且RQ2和RQ3与它们所连接的碳原子一起形成环Q,其是任选地取代的5元硫代-内酰胺环。
在第二方面,提供了一种用于生产以上所定义的具有式(X)的化合物的方法,其中环Q被R1取代,所述方法包括:
(i)使具有式(A)的化合物与丙烯酸乙酯在钯催化下反应以给出具有式(B)的化合物
其中环A是在环碳上被Hal取代的吡唑环,Hal是碘、溴或氯,RB2是在环氮上的取代基并且是C1-C3烷基或C1-C3氟烷基,n是1或2的整数,RB3是在环碳上的取代基并且每个RB3独立地是卤素、C1-C3氟烷基、C1-C3卤代烷氧基、C1-C3烷氧基、C1-C3卤代烷基、C1-C3氟烷基、C1-C3卤代烷氧基、C1-C3烷氧基、或C1-C3烷基;
(ii)使来自步骤(i)的所述具有式(B)的化合物与具有式(C)的化合物在环加成反应中反应,
其中R1选自由以下组成的组:C1-C6烷基、C2-C6烯基、C3-C6环烷基、C3-C6环烯基、任选地取代的苯基、任选地取代的C5-C6杂芳基、-CR12R13、-C(O)R12;R12是氢、OH、C1-C3烷氧基、或C1-C4烷基;R13是-C(O)NH2;
以得到具有式(D)和(E)的化合物的混合物;
(iii)使所述具有式(E)的化合物与氢氧化物碱在水/醚混合溶剂体系中反应以给出所述具有式(X)的化合物
其中A、RB2、RB3、n和R1是如以上步骤(i)和(ii)中所定义的。
具有式(B)、(D)和(E)的化合物也是新颖的并且形成本发明的又另外的方面。
如本文使用的,除非另外指明,否则术语“卤素”或“卤代”是指氟(fluorine,fluoro)、氯(chlorine,chloro)、溴(bromine,bromo)或碘(iodine,iodo),优选氟、氯或溴。
如本文使用的,氰基意指-CN基团。
如本文使用的,羟基意指-OH基团。
如本文使用的,硝基意指-NO2基团。
每个烷基部分,单独地或作为更大的基团(如烷氧基、烷硫基、卤代烷基、卤代烷氧基等)的一部分,可以是直链或支链的,并且如本文使用的,该术语具体地还包括环丙基。典型地,烷基是例如甲基、乙基、正丙基、环丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、正戊基、新戊基、或正己基。烷基通常是C1-C6烷基(除了在已经更狭窄地定义时),但优选地是C1-C4烷基或C1-C3烷基,并且更优选地是C1或C2烷基(即甲基或乙基)。
如本文使用的,术语“C1-C3烷氧基”是指具有式-ORa的基团,其中Ra是如上一般定义的C1-C3烷基。C1-C3烷氧基的实例因此包括甲氧基、乙氧基、丙氧基和异丙氧基。
如本文使用的,术语“C1-C3卤代烷基”是指如上一般定义的C1-C3烷基基团,其被一个或多个相同或不同的卤素原子取代。C1-C3卤代烷基的实例因此包括氟甲基、二氟甲基、三氟甲基、氯甲基、二氯甲基、三氯甲基、2,2,2-三氟乙基、2-氟乙基、2-氯乙基、五氟乙基、1,1-二氟-2,2,2-三氯乙基、2,2,3,3-四氟乙基和2,2,2-三氯乙基。
如本文使用的,术语“C1-C3卤代烷氧基”是指如上所定义的C1-C3烷氧基,其被一个或多个相同或不同的卤素原子取代。C1-C3卤代烷氧基的实例因此包括氟甲氧基、二氟甲氧基、三氟甲氧基、2,2,2-三氟乙氧基、1,1,2,2-四氟乙氧基、2-氟乙氧基、2-氯乙氧基、2,2-二氟乙氧基和2,2,2-三氯乙氧基。
术语“C1-C6-烷硫基”是指基团C1-C6烷基-S-,并且是例如甲硫基、乙硫基、丙硫基、异丙硫基、正丁硫基、异丁硫基、仲丁硫基或叔丁硫基,优选地是甲硫基或乙硫基。
术语“C1-C6烷基亚磺酰基”是指基团C1-C6烷基-S(O)-,并且是例如甲基亚磺酰基、乙基亚磺酰基、丙基亚磺酰基、异丙基亚磺酰基、正丁基亚磺酰基、异丁基亚磺酰基、仲丁基亚磺酰基或叔丁基亚磺酰基,优选地是甲基亚磺酰基或乙基亚磺酰基。
术语“C1-C6烷基磺酰基”是指基团C1-C6烷基-S(O)2-,并且是例如甲基磺酰基、乙基磺酰基、丙基磺酰基、异丙基磺酰基、正丁基磺酰基、异丁基磺酰基、仲丁基磺酰基或叔丁基磺酰基,优选地是甲基磺酰基或乙基磺酰基。
具有式(X)的化合物可以作为不同的几何异构体或以不同的互变异构的形式存在。本发明涵盖了所有的此类异构体和互变异构体,以及它们的处于所有比例的混合物,连同同位素形式(如氘化的化合物)的用途。它们可以含有一个或多个不对称中心并且因此可以产生光学异构体和非对映异构体。尽管没有相对于立体化学示出式(X),但本发明包括所有此类光学异构体和非对映异构体连同外消旋的和拆分的在对映异构体意义上纯的R和S立体异构体以及这些R和S立体异构体的其他混合物及其农用化学上可接受的盐的用途。应认识到某些光学异构体或非对映异构体可以具有超越另一种的有利特性。因此,在对本发明进行披露并且要求保护时,当披露外消旋混合物时,明显地考虑了对两种光学异构体(包括非对映异构体)(实质上不含另一种)进行了披露并且要求保护。
类似地,在具有式(D)、(E)、(H)和(I)的化合物中一个或多个可能的不对称碳原子的存在意味着这些化合物还可以以手性异构体形式即对映异构体或非对映异构体的形式存在。作为围绕单键的受限旋转的结果,还可能存在阻转异构体。式(D)、(E)、(H)和(I)旨在包括所有那些可能的异构体形式及其混合物。本发明包括具有式(D)、(E)、(H)和(I)的化合物的所有那些可能的异构体形式及其混合物。同样地,式(D)、(E)、(H)和(I)旨在包括所有可能的互变异构体(包括内酰胺-内酰亚胺互变异构和酮-烯醇互变异构)(当存在时)。本发明因此包括具有式(D)、(E)、(H)和(I)的化合物的所有可能的互变异构体形式的用途。
适合的盐包括衍生自碱金属或碱土金属的那些以及衍生自氨和胺的那些。优选的阳离子包括钠、钾、镁以及具有式N+(R119R120R121R122)的铵阳离子,其中R119、R120、R121和R122独立地选自氢、C1-C6烷基和C1-C6羟基烷基。具有式(I)的化合物的盐可以通过用金属氢氧化物(如氢氧化钠)或胺(如氨、三甲胺、二乙醇胺、2-甲硫基丙胺、双烯丙基胺、2-丁氧基乙胺、吗啉、环十二胺或苄胺)对具有式(I)的化合物进行处理来制备。胺盐经常是具有式(I)的化合物的优选形式,因为它们是可溶于水的并且使得它们适于制备希望的基于水的除草组合物。
当本发明的化合物含有碱部分时,可接受的盐可以由有机酸和无机酸形成,例如乙酸、丙酸、乳酸、柠檬酸、酒石酸、琥珀酸、富马酸、马来酸、丙二酸、扁桃酸、苹果酸、邻苯二甲酸、盐酸、氢溴酸、磷酸、硝酸、硫酸、甲磺酸、萘磺酸、苯磺酸、甲苯磺酸、樟脑磺酸以及类似地已知可接受的酸。
如本文使用的术语“除草剂”意指控制或改变植物生长的化合物。术语“除草有效量”意指能够对植物生长产生控制或改变作用的这样一种化合物或此类化合物的组合的量。控制或改变的作用包括所有从自然发育的偏离,例如,杀死、阻滞、叶灼伤、白化病、矮化病等。
本发明是基于以下一般化的反应方案,其中环A、RB2、RB3、n、R1和R2是如本文中所定义的。
反应方案1
使希望的卤化的吡唑(A)与丙烯酸乙酯在钯催化下反应,以提供具有式(B)的取代的乙烯基吡唑。取代的乙烯基吡唑(B)与具有式(C)的二硫戊环-异氰酸酯亚甲基亚胺(dithiolane-isocyanate iminiummethylide)经历环加成,提供了吡咯烷环加成物(即具有式(D)的化合物和具有式(E)的化合物)的混合物,其可以通过色谱法分离。使希望的吡咯烷环加成物(在以上反应方案中,例举了具有式(E)的化合物)与氢氧化物碱在水/醚混合溶剂体系中反应以提供具有式(X)的3-羧基取代的硫代内酰胺。具有式(C)的化合物可以如Tetrahedron Lett.[四面体快报]1995,36:9409中所述的制备。具有式(A)的卤化的吡唑是已知的或者可以根据本领域中熟知的方法制备。
根据希望的最终终产物,3-羧基-取代的硫代内酰胺可以使用标准的酰胺偶联条件与具有式(G)的苯胺偶联以提供希望的具有式(H)的硫代内酰胺-甲酰胺,所述条件如在合适的溶剂如二氯甲烷中的丙烷磷酸酐与合适的碱,如下面反应方案2所示。技术人员将理解,R2的选择取决于希望的最终终产物,并且因此可以是可被酰胺连接的任何合适的取代基。
反应方案2
所得具有式(H)的硫代内酰胺-甲酰胺可随后经历用过氧化氢溶液和合适的酸的氧化水解以形成具有式(I)的内酰胺化合物(反应方案3)。
反应方案3
可替代地,具有式(X)的3-羧基-取代的硫代内酰胺可随后经历用过氧化氢溶液和合适的酸的氧化水解以形成具有式(J)的内酰胺化合物,如反应方案4中所示的。这随后可使用如上所述的标准酰胺偶联条件与具有式(G)的苯胺偶联以提供希望的具有式(H)的内酰胺化合物(参见以下反应方案5)。
反应方案4
反应方案5
单个对映异构体能通过手性分离制备,如果需要的话。技术人员将理解,具有式(D)、(E)、(X)、(H)、(I)和(J)的化合物可以以以下项的不同的对映异构体形式存在,例如:
(i)具有式(D)的化合物
(ii)具有式(E)的化合物
(iii)具有式(X)的化合物
(iv)具有式(H)的化合物
(v)具有式(I)的化合物
(vi)具有式(J)的化合物
在每种情况下,在一组实施例中,以下对映异构体是优选的(D1)、(E1)、(X1)、(H1)、(I1)和(J1)。
在如本文中所述的具有式(A)、(B)、(D)、(E)、(X)、(H)和(I)的化合物中,环A是带有至少两个取代基的吡唑部分,其中所述取代基之一(RB2)由环氮携带,并且第二个取代基(RB3)携带在环碳原子上。明显地在此种构型下,A是碳与分子的其余部分连接。
当A是二取代的并且RB3在与取代的环氮原子相邻的环碳原子上携带时,所述RB3取代基可被定义为RB3SN。为了避免疑问,RB3SN是仅用于表示吡唑部分内的位置布置的RB3的子定义,并且因此RB3SN也选自由卤素、C1-C3氟烷基、C1-C3卤代烷氧基、C1-C3烷氧基、和C1-C3烷基组成的组。因此,当A是二取代的时,它可以由基团A1、A2、A3、A4或A5表示,如下所示,其中RB2、RB3和RB3SN是如上所定义的并且锯齿状线表示与相关分子的其余部分的附接点。在具有式(A)的化合物中,这是与相关的卤素原子的附接点。在具有式(B)的化合物中,这是与乙基-丙烯酸酯部分的附接点。在具有式(D)和(E)的化合物中,这是与1,4-二噻-6-氮杂螺[4.4]壬烷-8-甲酸酯部分的附接点。在具有式(X)、(H)和(I)的化合物中,这是通到(硫代)内酰胺环的4-位处的碳原子的附接点。
基团A1和A2是特别优选的,其中A2是二取代的吡唑中最优选的。
当环A是三取代的时,它可以由基团A6或A7表示,其中第三取代基(RB3)也在环碳原子上携带:
其中RB2、RB3和RB3SN和锯齿状线是如上所定义的。
优选地,RB2选自由以下组成的组:甲基、乙基、正丙基、氟甲基、三氟甲基、氟乙基、二氟乙基和三氟乙基。更优选地,RB2选自由以下组成的组:甲基、乙基、正丙基、三氟甲基和二氟乙基。还更优选地,RB2选自由以下组成的组:甲基、乙基和二氟乙基。
优选地,RB3和/或RB3SN各自独立地选自氯、氟、溴、甲基、乙基、二氟甲基、三氟甲基、C1-C3卤代烷氧基、C1-C3烷氧基、或C1-C3烷基。技术人员将理解,当环A是三取代的时,RB3和RB3SN可以是相同的或不同的。
在如本文中所定义的具有式(X)的化合物中,RQ1和RQ4各自是氢,并且RQ2和RQ3与它们所连接的碳原子一起形成环Q,其是任选地取代的5元硫代-内酰胺环。在优选的实施例中,Q具有结构Q1或Q2,其中‘a’表示与环A的附接点,并且‘c’表示与甲酸酯部分的附接点
在优选的实施例中,具有式(A)的化合物中的Hal取代基是碘或溴。
具有式(X)的化合物可用作包含吡唑并-吡咯烷酮基序的药物和农用化学品的制造中的中间体。例如,US2007/0123508描述了用作PAR2抑制剂的2-氧代-1-吡咯烷酮衍生物,具有式(X)的化合物可用于合成此类化合物,其中US2007/0123508的化合物的R1是取代的吡唑。US2004/0242671描述了用作治疗运动障碍的治疗剂的2-氧代-1-吡咯烷衍生物;具有式(X)的化合物可用于此类化合物,其中US 2004/0242671的式(II)的R3是二-/三-取代的吡唑并且R4是酰胺基。
US 4,874,422描述了作为除草剂的1-苯基-3-羧酰胺基吡咯烷酮,并且具有式(X)的化合物可用于制造如其中描述的具有式(I)的化合物,但是其中R3是二取代的吡唑。本文中还描述了使用具有式(X)的化合物的新颖的除草化合物的制造。
因此,在另外的方面,提供了具有式(X)的化合物在农用化学品的制备、特别是在除草剂的制备中的用途,以及具有式(X)的化合物在药物、特别是用于预防和/或治疗与PAR2相关的疾病和病症、和/或治疗运动障碍的药物的制备中的用途。
根据希望的最终终产物,R1选自由以下组成的组:C1-C6烷基、C2-C6烯基、C3-C6环烷基、C3-C6环烯基、任选地取代的苯基、任选地取代的C5-C6杂芳基、-CR12R13、或-C(O)R12;R12是氢、OH、C1-C3烷氧基、或C1-C4烷基。R13是-C(O)NH2。
当被取代时,所述苯基或C5-C6杂芳基优选地被1、2或3个R11取代基取代。
每个R11独立地是卤素、OH、C1-C6烷基、C1-C6卤代烷基、C1-C6烷氧基、C1-C6卤代烷氧基、C1-C3烷氧基-C1-C3烷基、C2-C6烯基、C2-C6炔基、硝基、氰基、或氨基。
在一个实施例中R1是3-CF3-苯基-。
更优选地,R1是C1-C3烷基、或-CR12R13。优选地,R12是甲基或乙基、更优选地乙基。更优选地,R1是甲基。
合适的R2取代基的实例包括氢、C1-C6烷基、-Cr烷氧基Cs烷基、C1-C6卤代烷基、-Cr烷氧基Cs卤代烷基、C2-C6烯基、C2-C6炔基、和-(CR21R22)tR20,其中每个R20独立地是-C(O)OR23,-OC(O)R23,-C3-C6环烷基,或-芳基、-芳氧基、-杂芳基、-杂芳氧基或-杂环基环,其中所述环任选地被1至3个独立的R25取代;r是1、2、3、4、或5的整数,s是1、2、3、4、或5的整数,并且r+s之和小于或等于6;t是0、1、2、3、4、5或6的整数,每个R21独立地是氢或C1-C2烷基;每个R22独立地是氢或C1-C2烷基;R23是氢或C1-C4烷基。
在某些实施例中,当R2是任选地被1至3个R25取代的芳基或杂芳基环,并且所述芳基或杂芳基环选自由苯基、吡啶基、和噻吩基环体系组成的组时,它可以由以下一般结构表示
其中环B是苯基、吡啶基、或噻吩基环,p是0、1、2、或3的整数,并且锯齿状线表示环与分子的其余部分的附接点,在此情况下中经由酰胺氮。
在某些实施例中,R2选自由R2-1、R2-2、R2-3、R2-4、R2-5和R2-6组成的组,其中p和锯齿状线是如前所述的,并且每个R25独立地是卤素、C1-C6烷基、C1-C6卤代烷基、C1-C6烷氧基、C1-C6卤代烷氧基、氰基、硝基、C1-C6烷硫基、C1-C6烷基亚磺酰基、或C1-C6烷基磺酰基。
更优选地,每个R25独立地是卤素、C1-C4烷基、C1-C3卤代烷基、C1-C3烷氧基、或C1-C3卤代烷氧基;甚至更优选地氯、氟、溴、C1-C2卤代烷基、C1-C2卤代烷氧基、或C1-C2烷氧基;还更优选地氟、乙基、三氟甲基、二氟乙基、甲氧基、二氟甲氧基、或三氟甲氧基。如本文中所述,p的值为1、2或3。优选地,p是0、1、或2并且每个R25由环碳原子携带。
在一组特定的具有式(H)和式(I)的化合物的实施例中,p是2并且至少一个R25是氟。优选地,p是0、1、或2并且每个R25由环碳原子携带。
如上所述,具有式(B)、(D)、(E)、(X)、(H)和(I)的化合物是新颖的,具有式(J)的化合物也是新颖的,并且这些化合物都形成本发明的又另外的方面。以下表1至表7给出了落入本发明范围内的这些化合物的具体实例。
表1如本文中所述的使用的具有式(B)的化合物
表2如本文中所述的使用的具有式(D)的化合物
表3-如本文中所述的使用的具有式(E)的化合物
表4如本文中所述的使用的具有式(X)的化合物
表5如本文中所述的具有式(H1)的化合物
表6如本文中所述的具有式(I1)的化合物
表7如本文中所述的使用的具有式(J)的化合物
实例
实例1:除草化合物N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺的制备
盐(I)可以如Tetrahedron Lett.[四面体快报]1995,36,9409中所述的制备。
步骤1(E)-3-[1-甲基-5-(三氟甲基)吡唑-3-基]丙-2-烯酸乙酯
在大的微波小瓶中将3-碘-1-甲基-5-(三氟甲基)吡唑(3.62mmol,1.00g)溶解在乙腈(15.2mL)中,添加丙烯酸乙酯(1.19mL,10.9mmol)、三乙胺(0.507mL,3.64mmol)、三-邻甲苯基膦(0.362mmol,0.110g)和乙酸钯(II)(0.362mmol,0.0813g),将搅拌的橙色溶液上方的空气空间用氮气吹扫,并且将小瓶密封并在110℃在微波辐射下加热60分钟。将反应混合物过滤(通过用小部分的EtOAc冲洗),并且将合并的滤液和洗涤液浓缩以除去大部分溶剂。将其余的橙色-棕色液体用水(12mL)稀释并且用EtOAc(3×15mL)萃取。将橙色萃取物合并,用水(10mL)洗涤,使其通过相分离柱、然后浓缩。柱色谱法(EtOAc/异己烷梯度洗脱)给出呈黄色油状物的(E)-3-[1-甲基-5-(三氟甲基)吡唑-3-基]丙-2-烯酸乙酯,0.51g(57%)。
1H NMR:(400MHz,CDCl3):δ=7.58(d,J=16.1Hz,1H),6.81(s,1H),6.43(d,J=16.1Hz,1H),4.26(q,J=7.1Hz,2H),4.01(d,J=0.6Hz,3H),1.33(t,J=7.1Hz,3H)。
步骤2 6-甲基-8-[1-甲基-5-(三氟甲基)吡唑-3-基]-1,4-二噻-6-氮杂螺[4.4]壬烷-9-甲酸乙酯
向在-50℃下在氮气气氛下搅拌的精细分散的氟化铯(12.7mmol,1.93g)在四氢呋喃(9.51mL)中的悬浮液中添加(E)-3-[1-甲基-5-(三氟甲基)吡唑-3-基]丙-2-烯酸乙酯(3.17mmol,0.787g)和亚1,3-二硫戊环-2-亚基-甲基-(三甲基甲硅烷基甲基)铵的溶液;在大约15分钟内滴加在四氢呋喃(39.51mL)中的三氟甲磺酸(5.55mmol,2.06g),保持反应温度低于-45℃。允许所得非常淡的黄色浑浊悬浮液缓慢升温至室温并且继续搅拌过夜。然后将反应混合物用DCM稀释并过滤,通过用另外部分的DCM进行洗涤。浓缩合并的滤液和洗涤液,并且通过柱色谱法(EtOAc/环己烷梯度洗脱)纯化的粗物质给出呈淡黄色油状物的6-甲基-8-[1-甲基-5-(三氟甲基)吡唑-3-基]-1,4-二噻-6-氮杂螺[4.4]壬烷-9-甲酸乙酯,566mg(45%)。
1H NMR:(400MHz,CDCl3):δ=6.45(s,1H),4.31-4.17(m,2H),3.90(d,J=0.6Hz,3H),3.89-3.79(m,2H),3.35-3.06(m,5H),2.97-2.91(m,1H),2.47(s,3H),1.31(t,J=7.2Hz,3H)。
步骤3 1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-硫代-吡咯烷-3-甲酸
向6-甲基-8-[1-甲基-5-(三氟甲基)吡唑-3-基]-1,4-二噻-6-氮杂螺[4.4]壬烷-9-甲酸乙酯(1.43mmol,0.566g)在二噁烷(34.3mL)和水(11.4mL)中的溶液中添加LiOH(14.3mmol,0.343g),并且将搅拌的混合物在氮气气氛下加热至60℃持续1小时。然后允许反应混合物冷却至约35℃,然后将其浓缩以除去大部分二噁烷。将其余的混合物用水(10mL)稀释,并分配在稀HCl(5mL,至pH 3)与DCM(20mL)之间。将两相混合物过滤以除去精细固体,然后分离有机相。将水溶液进一步用DCM(2×15mL)萃取,并将所有有机萃取物合并、经MgSO4干燥、过滤并将滤液浓缩,给出呈浅黄色固体的1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-硫代-吡咯烷-3-甲酸,399mg(90%)。
1H NMR:(400MHz,CDCl3):δ=6.66(s,1H),4.19-4.03(m,4H),3.93(d,J=0.5Hz,3H),3.34(s,3H)。
步骤4N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-硫代-吡咯烷-3-甲酰胺
向1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-硫代-吡咯烷-3-甲酸(0.340g,1.11mmol)在DCM(8.0mL)中的溶液中添加2,3-二氟苯胺(0.112mL,1.11mmol),给出淡黄色溶液。添加在乙酸乙酯(1.88mmol,1.12mL)中的丙基膦酸酐(50质量%),随后添加N,N-二异丙胺(3.32mmol,0.578mL),并且将反应混合物在室温下搅拌1小时。然后通过在搅拌下添加水(2mL)淬灭反应混合物,将其转移到相分离柱中并且收集有机物并浓缩。柱色谱法(EtOAc/异己烷梯度洗脱)给出呈无色结晶固体的N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-硫代-吡咯烷-3-甲酰胺,264mg(57%)。
1H NMR:(400MHz,CDCl3):δ=10.25(br s,1H),8.01(tdd,J=1.6,6.6,8.3Hz,1H),7.04(ddt,J=2.1,5.9,8.3Hz,1H),6.94-6.86(m,1H),6.58(s,1H),4.40(td,J=6.3,8.6Hz,1H),4.20(d,J=6.4Hz,1H),4.13(dd,1H),4.00(dd,1H),3.93(d,3H),3.33(s,3H)。
步骤5N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺
向搅拌的并在冰盐浴中冷却至约0至-5℃的N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-硫代-吡咯烷-3-甲酰胺(0.621mmol,0.260g)在乙腈(6.21mL)中的溶液中滴加50%过氧化氢(0.746mL),并且得到白色悬浮液。在5分钟后,滴加45%的氢溴酸水溶液(0.0750mL,0.621mmol)并且在搅拌10分钟后允许混合物升温至室温。3小时后,将反应混合物再冷却至5℃,并且用硫代硫酸钠溶液(约10mL)淬灭。将混合物用EtOAc(15mL)和水(10mL)稀释,并且分离有机相。将水溶液进一步用EtOAc(2×10mL)萃取,然后合并有机萃取物,运行通过相分离柱然后将其浓缩,给出无色胶状物。柱色谱法(EtOAc/异己烷梯度洗脱)给出呈白色结晶固体的N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺,210mg(84%)。
1H NMR:(400MHz,CDCl3):δ=10.15(br s,1H),8.04(dd,J=6.6,8.3Hz,1H),7.06-6.99(m,1H),6.89(br dd,J=1.1,8.6Hz,1H),6.69(s,1H),4.09(q,1H),3.94(s,3H),3.78(d,J=9.5Hz,1H),3.76-3.65(m,2H),2.98(d,3H)。
可以使用Chiralpak IA,10×250mm,5μm柱,用sc-CO2(溶剂A)、B=异丙醇(溶剂B)作为溶剂在以下等度条件下将外消旋的N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺分离以提供对映异构体(3S,4R)-N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺和(3R,4S)-N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺:85%溶剂A:15%溶剂B,在15mL/min下。
另外的具有式(I)的除草化合物的实例使用本文中所述的本发明的方法和化合物、以直接类似于以上实例1中所述的N-(2,3-二氟苯基)-1-甲基-4-[1-甲基-5-(三氟甲基)吡唑-3-基]-2-氧代-吡咯烷-3-甲酰胺的方式制备。这些化合物的结构和特征NMR数据在以下表8中给出。
表8使用本发明的化合物和方法制备的具有式(I)的除草化合物。虽然给出了优选的除草对映异构体的名称,但是在每种情况下,NMR数据对应于各自的外消旋体的NMR数据
Claims (6)
1.一种具有式(B)的化合物
其中,
环A是二-或三-取代的吡唑,在一个环氮上被RB2取代并且在至少一个环碳上被RB3取代;
RB2是C1-C3烷基或C1-C3氟烷基;
n是1或2的整数;
每个RB3独立地是卤素、C1-C3氟烷基、C1-C3卤代烷氧基、C1-C3烷氧基、C1-C3卤代烷基、或C1-C3烷基。
2.如权利要求1所述的具有式(B)的化合物,其中环A是A1、A2、A3、A4、A5、A6或A7
其中
RB2和RB3如权利要求1中所定义,RB3SN是位于与被RB2取代的氮原子相邻的碳原子上的RB3取代基,并且锯齿状线表示与具有式(B)的化合物的其余部分的附接点。
3.如权利要求1或2所述的具有式(B)的化合物,其中RB2选自由以下组成的组:甲基、乙基、正丙基、氟甲基、三氟甲基、氟乙基、二氟乙基和三氟乙基;其中RB3和/或RB3SN各自独立地选自氯、氟、溴、甲基、乙基、二氟甲基、三氟甲基、C1-C3卤代烷氧基和C1-C3烷氧基。
4.如权利要求1或2所述的具有式(B)的化合物,其中RB2选自由以下组成的组:甲基、乙基和二氟乙基。
5.如权利要求3所述的具有式(B)的化合物,其中RB2选自由以下组成的组:甲基、乙基和二氟乙基。
6.如权利要求1所述的具有式(B)的化合物,所述化合物选自在下表中指名为1.001、1.002、1.003、1.004、1.005、1.006、1.007和1.008的化合物的组:
。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1901559.3A GB201901559D0 (en) | 2019-02-05 | 2019-02-05 | Herbicidal compositions |
GB1901559.3 | 2019-02-05 | ||
PCT/EP2020/052782 WO2020161148A2 (en) | 2019-02-05 | 2020-02-04 | Pyrazole derivatives |
CN202080012473.7A CN113412254A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080012473.7A Division CN113412254A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117700363A true CN117700363A (zh) | 2024-03-15 |
Family
ID=65997122
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311588227.8A Pending CN117700363A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202080012473.7A Pending CN113412254A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202410524617.7A Pending CN118440059A (zh) | 2019-02-05 | 2020-02-04 | 除草混合物 |
CN202311588226.3A Pending CN117658988A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202080012476.0A Active CN113423270B (zh) | 2019-02-05 | 2020-02-04 | 除草混合物 |
CN202311588225.9A Pending CN117683024A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202080012471.8A Active CN113423690B (zh) | 2019-02-05 | 2020-02-05 | 吡唑衍生物 |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080012473.7A Pending CN113412254A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202410524617.7A Pending CN118440059A (zh) | 2019-02-05 | 2020-02-04 | 除草混合物 |
CN202311588226.3A Pending CN117658988A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202080012476.0A Active CN113423270B (zh) | 2019-02-05 | 2020-02-04 | 除草混合物 |
CN202311588225.9A Pending CN117683024A (zh) | 2019-02-05 | 2020-02-04 | 吡唑衍生物 |
CN202080012471.8A Active CN113423690B (zh) | 2019-02-05 | 2020-02-05 | 吡唑衍生物 |
Country Status (15)
Country | Link |
---|---|
US (11) | US11472792B2 (zh) |
EP (3) | EP3920700A1 (zh) |
JP (3) | JP2022519857A (zh) |
KR (1) | KR20210125022A (zh) |
CN (7) | CN117700363A (zh) |
AU (3) | AU2020218608A1 (zh) |
BR (2) | BR112021015296A2 (zh) |
CA (3) | CA3128447A1 (zh) |
CL (1) | CL2021001983A1 (zh) |
CO (1) | CO2021010365A2 (zh) |
EA (1) | EA202192135A1 (zh) |
GB (1) | GB201901559D0 (zh) |
IL (1) | IL284977A (zh) |
MX (1) | MX2021009422A (zh) |
WO (3) | WO2020161147A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11589583B2 (en) | 2013-12-03 | 2023-02-28 | Fmc Corporation | Pyrrolidinones herbicides |
GB201901559D0 (en) | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
WO2020242946A1 (en) * | 2019-05-24 | 2020-12-03 | Fmc Corporation | Pyrazole-substituted pyrrolidinones as herbicides |
GB202012143D0 (en) * | 2020-08-05 | 2020-09-16 | Syngenta Crop Protection Ag | Herbicidal compounds |
GB202012651D0 (en) * | 2020-08-13 | 2020-09-30 | Syngenta Crop Protection Ag | Herbicidal compositions |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302239A (en) | 1980-02-19 | 1981-11-24 | Ppg Industries, Inc. | 3-(5- or 3-Substituted-5- or 3-isoxazolyl)-1-allyl or alkyl-4-substituted-5-substituted or unsubstituted-2-imidazolidinones for controlling weeds |
CA1205077A (en) | 1983-03-28 | 1986-05-27 | Jay K. Rinehart | Herbicidally active 3-isoxazolyl-2-imidazolidinone derivatives |
US4600430A (en) | 1985-02-22 | 1986-07-15 | Eli Lilly And Company | Pyridinylimidazolidinone compounds |
US4874422A (en) * | 1988-12-27 | 1989-10-17 | Ici Americas Inc. | 1-Phenyl-3-carboxyamidopyrrolidones and their use as herbicides |
US5763470A (en) | 1995-06-07 | 1998-06-09 | Sugen Inc. | Benzopyran compounds and methods for their use |
AR031027A1 (es) | 2000-10-23 | 2003-09-03 | Syngenta Participations Ag | Composiciones agroquimicas |
CA2461961A1 (en) | 2001-10-08 | 2003-04-17 | Ucb, S.A. | Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders |
PE20040609A1 (es) * | 2002-11-01 | 2004-10-29 | Takeda Pharmaceutical | Compuestos heterociclicos aromaticos como promotores de un factor neurotrofico |
DE10300124A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Verfahren zur Herstellung von Arylalkinen |
CH697574B1 (de) * | 2003-01-07 | 2008-12-15 | Lanxess Deutschland Gmbh | Pyrazolylarylalkine. |
JP3899362B2 (ja) | 2003-03-14 | 2007-03-28 | あすか製薬株式会社 | Lyve−1のペプチドフラグメント及びそれに対する抗体 |
US20070123508A1 (en) | 2005-05-27 | 2007-05-31 | Roger Olsson | PAR2-modulating compounds and their use |
DK2680694T3 (en) * | 2011-02-28 | 2019-03-25 | Biomarin Pharm Inc | HISTONDEACETYLASE INHIBITORS |
US8957066B2 (en) * | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
UA118035C2 (uk) | 2013-10-07 | 2018-11-12 | Сінгента Партісіпейшнс Аг | Гербіцидні сполуки |
GB201318863D0 (en) | 2013-10-25 | 2013-12-11 | Syngenta Ltd | Herbicidal compounds |
CN106414403B (zh) | 2013-12-03 | 2019-08-30 | Fmc公司 | 吡咯烷酮除草剂 |
EP3087066A1 (en) | 2013-12-23 | 2016-11-02 | Syngenta Participations AG | Dihydro-hydantoin derivatives with herbicidal activity |
TWI659019B (zh) | 2014-02-28 | 2019-05-11 | 日商帝人製藥股份有限公司 | 吡唑醯胺衍生物 |
AR100776A1 (es) | 2014-06-16 | 2016-11-02 | Syngenta Participations Ag | Compuestos herbicidas |
MY184132A (en) | 2014-11-26 | 2021-03-20 | Visolis Inc | Processes for conversion of biologically derived mevalonic acid |
WO2016095089A1 (en) | 2014-12-15 | 2016-06-23 | Merck Sharp & Dohme Corp. | Erk inhibitors |
CN104844519A (zh) * | 2015-06-09 | 2015-08-19 | 浙江华海药业股份有限公司 | 一种制备依普罗沙坦杂质ep12a的方法 |
GB201617050D0 (en) * | 2016-10-07 | 2016-11-23 | Syngenta Participations Ag | Herbicidal mixtures |
WO2018177837A1 (de) * | 2017-03-30 | 2018-10-04 | Bayer Aktiengesellschaft | 4-cyclopentyl- und 4-cyclopropyl-2-oxopyrrolidin-3-carboxami d-derivate und verwandte verbindungen als herbizide pflanzenschutzmittel |
WO2018177836A1 (de) * | 2017-03-30 | 2018-10-04 | Bayer Aktiengesellschaft | N-cyclopropyl-2-oxopyrrolidin-3-carboxamid-derivate und verwandte verbindungen als herbizide pflanzenschutzmittel |
WO2019025156A1 (de) * | 2017-08-03 | 2019-02-07 | Bayer Aktiengesellschaft | Substituierte pyrrolidinone sowie deren salze und ihre verwendung als herbizide wirkstoffe |
TWI834637B (zh) * | 2018-03-01 | 2024-03-11 | 日商武田藥品工業有限公司 | 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯 |
GB201901559D0 (en) * | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
WO2020242946A1 (en) * | 2019-05-24 | 2020-12-03 | Fmc Corporation | Pyrazole-substituted pyrrolidinones as herbicides |
-
2019
- 2019-02-05 GB GBGB1901559.3A patent/GB201901559D0/en not_active Ceased
-
2020
- 2020-02-04 EP EP20703983.5A patent/EP3920700A1/en active Pending
- 2020-02-04 JP JP2021545787A patent/JP2022519857A/ja active Pending
- 2020-02-04 AU AU2020218608A patent/AU2020218608A1/en active Pending
- 2020-02-04 CN CN202311588227.8A patent/CN117700363A/zh active Pending
- 2020-02-04 CN CN202080012473.7A patent/CN113412254A/zh active Pending
- 2020-02-04 EA EA202192135A patent/EA202192135A1/ru unknown
- 2020-02-04 CN CN202410524617.7A patent/CN118440059A/zh active Pending
- 2020-02-04 WO PCT/EP2020/052780 patent/WO2020161147A1/en unknown
- 2020-02-04 JP JP2021545858A patent/JP2022519657A/ja active Pending
- 2020-02-04 EP EP20703984.3A patent/EP3921306A2/en active Pending
- 2020-02-04 CN CN202311588226.3A patent/CN117658988A/zh active Pending
- 2020-02-04 WO PCT/EP2020/052782 patent/WO2020161148A2/en active Application Filing
- 2020-02-04 CN CN202080012476.0A patent/CN113423270B/zh active Active
- 2020-02-04 BR BR112021015296-2A patent/BR112021015296A2/pt unknown
- 2020-02-04 CA CA3128447A patent/CA3128447A1/en active Pending
- 2020-02-04 AU AU2020219393A patent/AU2020219393A1/en active Pending
- 2020-02-04 KR KR1020217027433A patent/KR20210125022A/ko unknown
- 2020-02-04 MX MX2021009422A patent/MX2021009422A/es unknown
- 2020-02-04 CA CA3128444A patent/CA3128444A1/en active Pending
- 2020-02-04 CN CN202311588225.9A patent/CN117683024A/zh active Pending
- 2020-02-05 EP EP20704804.2A patent/EP3921307B1/en active Active
- 2020-02-05 US US16/782,530 patent/US11472792B2/en active Active
- 2020-02-05 US US16/782,796 patent/US11059806B2/en active Active
- 2020-02-05 CA CA3128449A patent/CA3128449A1/en active Pending
- 2020-02-05 JP JP2021545830A patent/JP2022519864A/ja active Pending
- 2020-02-05 BR BR112021015362-4A patent/BR112021015362A2/pt unknown
- 2020-02-05 CN CN202080012471.8A patent/CN113423690B/zh active Active
- 2020-02-05 AU AU2020217580A patent/AU2020217580A1/en active Pending
- 2020-02-05 US US16/782,866 patent/US10882846B2/en active Active
- 2020-02-05 WO PCT/EP2020/052892 patent/WO2020161199A1/en active Application Filing
- 2020-05-14 US US16/874,165 patent/US10947219B2/en active Active
- 2020-05-14 US US16/874,136 patent/US10851085B2/en active Active
- 2020-05-15 US US16/874,715 patent/US10865197B2/en active Active
- 2020-12-01 US US17/108,110 patent/US11548873B2/en active Active
-
2021
- 2021-01-29 US US17/161,788 patent/US11680057B2/en active Active
- 2021-07-19 IL IL284977A patent/IL284977A/en unknown
- 2021-07-28 CL CL2021001983A patent/CL2021001983A1/es unknown
- 2021-08-06 CO CONC2021/0010365A patent/CO2021010365A2/es unknown
-
2022
- 2022-09-15 US US17/945,221 patent/US12077525B2/en active Active
- 2022-12-07 US US18/062,744 patent/US11851420B2/en active Active
-
2023
- 2023-05-17 US US18/319,066 patent/US20230286954A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN117700363A (zh) | 吡唑衍生物 | |
JP4633462B2 (ja) | 3−ハロ−4,5−ジヒドロ−1h−ピラゾールの製造方法 | |
BG60410B2 (bg) | 2,6-заместени пиридинови производни | |
MX2011004648A (es) | Nuevos compuestos halosustituidos. | |
KR20040029434A (ko) | 치환된 디히드로 3-할로-1h-피라졸-5-카르복실레이트, 그의 제조 방법 및 용도 | |
JPH0667906B2 (ja) | 2,6−置換ピリジン化合物および除草剤 | |
CZ296302B6 (cs) | Zpusob prípravy 1-arylpyrazolových derivátu a meziprodukty tohoto zpusobu | |
WO2006004062A1 (ja) | 2,6-ジクロロ-4-ピリジルメチルアミン誘導体および農園芸用病害防除剤 | |
US6200933B1 (en) | 6-(Nonsubstituted or substituted) phenoxy picolinic acids, process of preparing the same, and agricultural/horticultural germicides containing the same | |
US4824954A (en) | Process for preparation of substituted pyridines | |
AU2017258665A1 (en) | Process for the preparation of herbicidal compounds | |
CN108707114B (zh) | 一种乙酰胺类化合物及其制备方法和应用 | |
JPH08245594A (ja) | 2−オキシアニリン誘導体および除草剤 | |
CN117886815A (zh) | 白叶藤碱盐衍生物及其在防治植物病毒和杀菌方面的应用 | |
JPWO2018105492A1 (ja) | 3−(ピリジル−2−アミノ)プロピオニトリル及びその類縁体の製造方法 | |
JP2002255962A (ja) | キノロンカルボン酸誘導体 | |
WO2002066444A1 (fr) | Composes 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine, procede de preparation correspondant et antiparasitaires a usages agricole et horticole | |
JPH1077270A (ja) | 2−(1−クロロビニル)ピリジン誘導体およびその製造方法 | |
PL191981B1 (pl) | Nowe pochodne 1,2-benzoizotiazolin-3-onu i sposób ich otrzymywania |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |